Why is Medikit Co., Ltd. ?
- The company has been able to generate a Return on Equity (avg) of 6.42% signifying low profitability per unit of shareholders funds
- Poor long term growth as Net Sales has grown by an annual rate of 4.20% and Operating profit at 3.58% over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 6.42% signifying low profitability per unit of shareholders funds
- INTEREST(9M) At JPY 5.76 MM has Grown at inf%
- ROCE(HY) Lowest at 6.54%
- DEBT-EQUITY RATIO (HY) Highest at -47.95 %
- The stock has generated a return of 10.69% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 59.79%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Medikit Co., Ltd. for you?
Low Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at 4.68 times
At JPY 5.76 MM has Grown at inf%
Lowest at 6.54%
Highest at -47.95 %
Lowest at 3.05 times
Lowest at 61,342.96
Grown by 22.69% (YoY
Lowest at JPY 44,097.9 MM
Lowest at JPY 1,180.85 MM
Lowest at 22.22 %
Lowest at JPY 687.34 MM
Here's what is working for Medikit Co., Ltd.
Debtors Turnover Ratio
Depreciation (JPY MM)
Here's what is not working for Medikit Co., Ltd.
Interest Paid (JPY MM)
Operating Profit to Interest
Debt-Equity Ratio
Inventory Turnover Ratio
Operating Profit (JPY MM)
Operating Profit to Sales
Pre-Tax Profit (JPY MM)
Cash and Cash Equivalents
Raw Material Cost as a percentage of Sales
Non Operating income






